Date | Total Non-Current Liabilities | Shareholders' Equity | Other Liabilities | Total Liabilities |
---|
CEO | Dr. Chandrashekhar Mainde |
IPO Date | Nov. 25, 2022 |
Location | India |
Headquarters | Sadoday Gyan |
Employees | 556 |
Sector | Healthcare |
Industries |
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.
Past 5 years
USD 11.16
USD 10.77
USD 10.92
USD 139.02
USD 14.57
StockViz Staff
February 2, 2025
Any question? Send us an email